Skip to content
No results
  • Gutenberg Blocks
    • Combined Blocks
    • Columns Block
    • Image & Gallery Block
    • Quote Block
    • Table Block
    • Button & Separator
  • Pages
    • Narrow Width
    • Default Width
    • Right Sidebar
    • Left Sidebar
  • About Us
  • Contact

Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

  • Partners
  • Press
  • About
  • Useful
PF Journal
  • Gutenberg Blocks
    • Combined Blocks
    • Columns Block
    • Image & Gallery Block
    • Quote Block
    • Table Block
    • Button & Separator
  • Pages
    • Narrow Width
    • Default Width
    • Right Sidebar
    • Left Sidebar
  • About Us
  • Contact
Contribute
PF Journal

Ceva Tops Q2 Targets On Edge AI Tech Licensing

  • aathaath
  • August 10, 2026
  • All News And Stock Ideas, Artificial Intelligence, Chip Stocks Semiconductor Industry News, Earnings, Tech Earnings, Technology

Ceva, a provider of silicon and software intellectual property for network edge applications, beat estimates for Q2. But Ceva stock fell.

The post Ceva Tops Q2 Targets On Edge AI Tech Licensing appeared first on Investor’s Business Daily.

< class="ct-module-title"> Trending now
Democrat Abdul El-Sayed defeats Republican Mike Rogers in key Michigan Senate race
Democrat Abdul El-Sayed defeats Republican Mike Rogers in key Michigan Senate race
Nevada Attorney General Aaron Ford beats Republican incumbent for governor
Nevada Attorney General Aaron Ford beats Republican incumbent for governor
'We have great leverage here': DNC chair Ken Martin on Democrats' midterms sweep
'We have great leverage here': DNC chair Ken Martin on Democrats' midterms sweep
Hakeem Jeffries is poised to become the first Black speaker of the House
Hakeem Jeffries is poised to become the first Black speaker of the House
  • Partners
  • Press
  • About
  • Useful

Popular Posts

CoreWeave, Nebius Slide As Blue Wave Clouds AI Boom

November 4, 2026

Charles River Labs, A Top 2% Medical Stock, Drops Despite Its Beat And Raise

November 4, 2026

Novo Surges 5% After Walloping Expectations On The Back Of Its GLP-1 Drugs

November 4, 2026

About Us

  • About Organization
  • Our Clients
  • Our Partners

Useful Information

Vim in meis verterem menandri, ea iuvaret delectus verterem qui, nec ad ferri corpora.

Euismod nisi porta lorem mollis. Interdum velit euismod in pellentesque.

Contact Info

Lorem ipsum dolor sit amet has ignota putent ridens aliquid indoctum anad movet graece vimut omnes.

  • Address: Street Name, NY 38954
  • Phone: 578-393-4937
  • Mobile: 578-393-4937
  • Website: creativethemes.com

PF Journal Copyright © 2003 - 2026 

Terms & Services | Privacy Policy